课题基金 / 基金详情

Towards Optimizing Value-Based Systemic Therapy in Metastatic Renal Cell Carcinoma: A Cost-Utility Analysis Using Decision Analytic Modeling of First-Line Systemic Therapy

优化转移性肾细胞癌基于价值的全身治疗：使用一线系统治疗决策分析模型进行成本效用分析

批准号：

406371

负责人：

Parmar Ambika

金额：

$1.27万

依托单位：

University of Toronto

依托单位国家：

加拿大

项目类别：

Studentship Programs

财政年份：

2018

资助国家：

加拿大

项目状态：

已结题

起止时间：

2018-12-01 至 2019-12-01

来源：

https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=406371&lang=en

关键词：

Cost-Effectiveness Decision-Analysis Health Services Research Health Technology Assessment Immunotherapy Oncology Renal Cell Carcinoma Targeted Therapy

项目摘要

项目成果

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

Given a better understanding of how kidney cancers behave, there have been several new drugs developed over the last decade that are effective against this disease. While this is exciting for patients, it creates a decision-making problem for clinicians t

期刊论文(0)

专著(0)

科研奖励(0)

会议论文